Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway

References

• Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(5):v8–v30.
   PubMed Web of Science ®Google Scholar
• Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26(4):1–18.
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Canc Netw. 2017;15(4):433–451.
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Anderson BO, Balassanian R, et al. Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(3):324–354.
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5.
   PubMed Web of Science ®Google Scholar
• Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Chakravarti D, Ganguli S, et al. Cancer and noncoding RNAs. Beijing, China: Elsevier; 2018. Chapter 25, Cancer noncoding RNA discovery through high-throughput sequencing; p. 463–477.
   Google Scholar
• Jiang Y-Z, Liu Y-R, Xu X-E, et al. Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value. Cancer Res. 2016;76(8):2105–2114.
   PubMed Web of Science ®Google Scholar
• Huang Z, Du G, Huang X, et al. The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway. EBioMedicine. 2018;38:162–170.
   PubMed Web of Science ®Google Scholar
• Qin Y, Roberts JD, Grimm SA, et al. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression. Genome Biol. 2018;19(1):7.
   PubMed Web of Science ®Google Scholar
• Lopez J, Tait S. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer. 2015;112(6):957.
   PubMed Web of Science ®Google Scholar
• Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016;16(8):539.
   PubMed Web of Science ®Google Scholar
• Hatok J, Racay P. Bcl-2 family proteins: master regulators of cell survival. Biomol Concepts. 2016;7(4):259–270.
   PubMedGoogle Scholar
• Ye X, Brabletz T, Kang Y, et al. Upholding a role for EMT in breast cancer metastasis. Nature. 2017;547(7661):E1.
   PubMed Web of Science ®Google Scholar
• Brabletz T, Kalluri R, Nieto MA, et al. EMT in cancer. Nat Rev Cancer. 2018;18(2):128.
   PubMed Web of Science ®Google Scholar
• Yang Y, Su Z, Song X, et al. Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster. Sci Rep. 2016;6(1):20961.
   PubMed Web of Science ®Google Scholar
• Tsai P-F, Dell’Orso S, Rodriguez J, et al. A muscle-specific enhancer RNA mediates cohesin recruitment and regulates transcription in trans. Molecular cell. 2018;71(1):129.e8–141.e8.
   Web of Science ®Google Scholar
• Léveillé N, Melo CA, Rooijers K, et al. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun. 2015;6(1):6520.
   PubMed Web of Science ®Google Scholar
• Creyghton MP, Cheng AW, Welstead GG, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci. 2010;107(50):21931–21936.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309.
   PubMed Web of Science ®Google Scholar
• Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3(3):221.
   PubMed Web of Science ®Google Scholar
• Biswas DK, Shi Q, Baily S, et al. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci. 2004;101(27):10137–10142.
   PubMed Web of Science ®Google Scholar
• Lin Z, Li W, Zhang H, et al. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma. Tumor Biol. 2016;37(3):3461–3468.
   PubMedGoogle Scholar
• Gu K, Li M-M, Shen J, et al. Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-κB/ZEB1 signal pathway. Am J Cancer Res. 2015;5(3):1169.
   PubMed Web of Science ®Google Scholar
• Wu Y-D, Zhou B. TNF-alpha/NF-kappaB/snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102(4):639.
   PubMed Web of Science ®Google Scholar
• Collins TS, Lee L-F, Ting J-Y. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-κB-and AP-1-dependent mechanism. Cancer Immunol, Immunother. 2000;49(2):78–84.
   PubMed Web of Science ®Google Scholar
• Russo RC, Garcia CC, Teixeira MM, et al. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Exp Rev Clin Immunol. 2014;10(5):593–619.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li A, Tian Y, et al. The CXCL8-CXCR1/2 pathways in cancer. Cytokine Growth Factor Rev. 2016;31:61–71.
   PubMed Web of Science ®Google Scholar
• Todorović-Raković N, Milovanović J. Interleukin-8 in breast cancer progression. J Interferon Cytokine Res. 2013;33(10):563–570.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ren Y, Dai Z-J, et al. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients. Adv Clin Exp Med. 2017;26(3):421–426.
   PubMed Web of Science ®Google Scholar
• Chen C, Duckworth C, Fu B, et al. Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis. Br J Cancer. 2014;110(3):741.
   PubMed Web of Science ®Google Scholar
• Hartman ZC, Poage GM, Den Hollander P, et al. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 2013;73(11):3470–3480.
   PubMed Web of Science ®Google Scholar